The Nomination Committee represents the company’s shareholders. It has the task of creating the best possible basis for the General Meeting’s decisions and submitting proposals for resolutions regarding e.g. the appointment of the Board and auditor and their remuneration. The 2011 Annual General Meeting resolved that the company shall have a Nomination Committee consisting of one representative for each of the four largest shareholders, in terms of the number of votes, and the Chairman of the Board of Directors. The Nomination Committe ahead of the 2012 Annual General Meeting comprises:
• Ulrik Spork, Novo A/S, also Chairman of the Nomination Committee
• Björn Odlander, HealthCap
• Claus Berner Møller, Arbejdsmarkedets Tillaegspension (ATP)
• Ulrica Slåne, Third Swedish National Pension Fund (AP3)
• Håkan Åström, Chairman of the Board of Orexo